Critical updates in an ever-changing environment.

In the latest episode of the “Pharmacy Friends” podcast, join Prime’s research team for a preview of the industry-leading and award-winning research that will be presented at flagship industry event

publications Trending Topics & Drug Approvals: September 2025 Your source for the latest drug information highlights September 30, 2025 Trending Topics Drug Approvals Trending Topics Hot topics...

Industry experts share new insights from PBM industry, including GLP-1 weight-loss drugs, biosimilars and rising pharmaceutical costs

Studies include Prime’s GLP-1 obesity research and a Medicare drug cost predictive model

Read Clinical News: May 2024 Your monthly source for drug information highlights Clinical News Your monthly source for drug information highlights Hot topics FDA ALERT ON PREGNANCY RISKS WITH...

Breadcrumb Prime Therapeutics Newsroom Custom Content Publications Clinical Highlights: October 2024 Publications Clinical Highlights: October 2024 Your monthly source for drug information...

Read Clinical News: April 2024 Your monthly source for drug information highlights Clinical News Your monthly source for drug information highlights Hot topics NEW PRESCRIPTION DIGITAL THERAPEUTIC...

Publications Clinical Highlights: December 2024 Your monthly source for drug information highlights. December 30, 2024 Weight Management Corner An analysis published in The Lancet details national-...

publications High-Cost Therapy Profile: July 2025 Rebisufligene etisparvovec Intravenous (IV) Metabolic gene therapy July 3, 2025 Proposed indications Sanfilippo A syndrome (Mucopolysaccharidosis...

publications Trending Topics & Drug Approvals: June 2025 Your source for the latest drug information highlights July 1, 2025 Trending Topics Hot topics On June 9, 2025, the United States (U.S.)...

This monthly approval update provides a review of newly approved specialty drugs, recent drug launches, generic updates, new indications and news of note on drugs in the approval process.

A roundup of Prime's award-winning presentations and insights at AMCP Nexus in National Harbor, Maryland

publications High-Cost Therapy Profile: August 2025 Apitegromab Intravenous (IV) | Scholar Rock, LLC Neuromuscular August 15, 2025 Proposed indications Spinal muscular atrophy (SMA) FDA...

Perspectives High-Cost Therapy Profile: January Detailed information about Atidarsagene Autotemcel Intravenous (IV) High Cost Therapy Profile Atidarsagene Autotemcel Intravenous (IV) Orchard ...

publications ASCO 2025 Spotlight: The Trials Making Headlines July 14, 2025 Author: Abby Kim, PharmD, BCOP The 2025 American Society of Clinical Oncology (ASCO) annual meeting lived up to its...

Publications Clinical Highlights: January 2025 Your monthly source for drug information highlights. January 30, 2025 Weight management corner The Lancet Diabetes & Endocrinology Commission has...

publications Fall 2025 Prime Therapeutics Report: Reimagining Cancer Care Explore the latest oncology trends, payer strategies and pipeline updates shaping the future of managed care. October 7,...

Read Clinical News: August 2024 Your monthly source for drug information highlights Clinical News Your monthly source for drug information highlights Hot topics FDA SAFETY ALERT ON COMPOUNDED...

cover image for Reimagine Cancer Care: Insights That Drive Smarter Decisions Explore the latest oncology trends, payer strategies and pipeline updates shaping the future of managed care. Prime...

In this episode, Prime/MRx clinicians — along with special guests — discuss the hottest topics covered at the Academy of Managed Care Pharmacy (AMCP)'s 2024 Annual Meeting in New Orleans

publications Summer 2025 Issue: Spotlight on HIV and Specialty Drug Trends New therapies, payer strategies and pipeline updates shaping the future of managed care July 15, 2025 The Prime...

cover image for summer 2025 New therapies, payer strategies and pipeline updates shaping the future of managed care  Prime Therapeutics /summer-2025-prime-therapeutics-report The Prime Therapeutics...

Read Clinical News: June 2024 Your monthly source for drug information highlights Clinical News Your monthly source for drug information highlights Hot topics MDMA-ASSISTED THERAPY FOR PTSD...

Journal of Managed Care & Specialty Pharmacy (JMCP)

Hear some of the latest insights from the annual managed care pharmacy event, where Prime Therapeutics clinical and health outcomes teams presented leading research findings

publications Trending Topics & Drug Approvals: August 2025 Your source for the latest drug information highlights August 29, 2025 Trending Topics Hot topics BARDA research update The United...

A roundup of Prime's award-winning presentations and insights at AMCP Nexus in Las Vegas.

Publications Clinical Highlights: March 2025 Your monthly source for drug information highlights. March 27, 2025 Trending topics As of late February 2025, the United States (U.S.) Centers for...

Identifying and managing diabetes and weight loss therapies earns AMCP platinum award

More than 300 pharma representatives attended this annual gathering to learn more about what Prime/MRx has to offer

publications Trending Topics & Drug Approvals: November 2025 Your source for the latest drug information highlights November 4, 2025 Trending Topics Drug Approvals Trending Topics Hot topics The...

Power your success with combined pharmacy and medical data Integrated data. Actionable insights. Pharmacist outreach. All in one innovative product. Breadcrumb Home Our solutions Clinical...

This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty drugs, new indications and recent first-time generic launches.

This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty drugs, new indications and recent first-time generic launches.

This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty drugs, new indications and recent first-time generic launches.

Read Drug Approvals Monthly Update: January 2024 Critical updates in an ever-changing environment. Drug Approval Update Specialty New drugs 12/22/2023 Wainua™ (eplontersen) The United States (U.S.)...

Annual conference gathers 2,500+ managed care leaders to discuss complex health care issues.

Read Drug Approvals Monthly Update: February 2024 This monthly approval update provides a review of newly approved specialty drugs, recent drug launches, generic updates, new indications and news...

publications High-Cost Therapy Profile: March 2025 Pegzilarginase Intravenous (IV), Subcutaneous (SC) | Immedica Metabolic March 14, 2025 Proposed indications Arginase 1 deficiency (ARG1-D)...

13th annual report the preeminent source for medical benefit drug trend

publications Spring 2024 Prime Therapeutics Report March 15, 2024 The Prime Therapeutics Report is your source for innovative managed care strategies, trends and updates. Our cover story (Page 6)...

Managed Healthcare Executive

Biobetters are just a nickname; they’re based on existing biologics but with a few key differences

Perspectives High-Cost Therapy Profile: April Detailed information about prademagene zamikeracel Topical surgical application Date High Cost Therapy Profile Gene therapy/Dermatology Prademagene...

Get the most value and best outcomes from C&GT Cell and gene therapies (C&GTs) represent breakthrough science, but often come at a high cost. Breadcrumb Home Our solutions Condition management Cell...

Perspectives High-Cost Therapy Profile: May Detailed information about Fidanacogene elaparvovec-dzkt Intravenous (IV) High Cost Therapy Profile Gene therapy/Hematology Fidanacogene elaparvovec-dzkt...

Breadcrumb Home Newsroom Custom Content Publications Drug Approvals Monthly Update: September 2024 PUBLICATIONS Drug Approvals Monthly Update: September 2024 This monthly update of United States...

Designed for unions, delivered with care At Prime Therapeutics (Prime), we built our model around transparency, flexibility and aligned incentives from the start. We don’t just help unions respond...

Read Drug Approvals Monthly Update: June 2024 This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty drugs, new...

PUBLICATIONS FDA Decisions Expected Drug pipeline for January 2025 December 17, 2024 Your monthly synopsis of new drugs expected to hit the market At Prime Therapeutics (Prime), we have positioned...

publications High Cost Therapy Profile: November 2024 Zenocutuzumab Intravenous (IV) November 20, 2024 Oncology Proposed indications Pancreatic ductal adenocarcinoma (PDAC) and non–small...

Read Drug Approvals Monthly Update: April 2024 This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty drugs, new...

publications Trending Topics & Drug Approvals: July 2025 Your source for the latest drug information highlights July 30, 2025 Trending Topics Hot topics Elevidys update Sarepta has resumed...

PUBLICATIONS FDA Decisions Expected: September 2025 Your monthly synopsis of new drugs expected to hit the market August 14, 2025 Drug pipeline for September 2025 At Prime Therapeutics (Prime), we...

Drug Approvals Quarterly Update: July 2024 This wrap-up provides a review of newly approved drugs, recent drug launches, new indications and news of note on drugs in the approval process....

PUBLICATIONS FDA Decisions Expected: March 2025 Your monthly synopsis of new drugs expected to hit the market February 14, 2025 Drug pipeline for March 2025 At Prime Therapeutics (Prime), we have...

publications FDA Decisions Expected Drug pipeline for November 2024 October 14, 2024 Your monthly synopsis of new drugs expected to hit the market At Prime Therapeutics (Prime), we have...

PUBLICATIONS FDA Decisions Expected: November 2025 Your monthly synopsis of new drugs expected to hit the market October 13, 2025 Drug pipeline for November 2025 At Prime Therapeutics (Prime), we...

Read Drug Approvals Monthly Update: May 2024 This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty drugs, new...